» Bayer Pays Millions to Settle Deep Vein Thrombosis Lawsuits

Bayer Pays Millions to Settle Deep Vein Thrombosis Lawsuits

Tampa, FL (Law Firm Newswire) August 20, 2012 – The drug manufacturer Bayer has paid millions of dollars to settle lawsuits involving pulmonary embolism or deep vein thrombosis (DVT).

The lawsuits were filed by women who used the company's Yaz or Yasmin birth control pills and subsequently developed blood clots.

“Pulmonary embolism and DVT are very serious conditions,” said Greg Grambor, a DVT expert and owner of Vascular PRN, a distributor of treatment devices. “While the causes vary, the best method of prevention is compression therapy, which can be accomplished with a variety of venous compression devices, designed for maximum patient safety and comfort.”

DVT occurs when a blood clot forms in the veins of the pelvis or the legs. If the clot breaks free and travels through the bloodstream, it becomes an embolism. Some of the plaintiffs in the Bayer case suffered from pulmonary embolism.

Since 2009, Bayer has faced more than 12,000 lawsuits by women who say that the birth control pills caused harmful side effects. Attorneys for the plaintiffs said that the FDA has linked at least 50 deaths to use of Yaz and Yasmin.

At present, Bayer is only settling the cases that allege pulmonary embolism or DVT. The German drug maker has so far agreed to pay more than $400 million to settle about 1,877 of the lawsuits. Experts predict the company may eventually pay out billions of dollars.

In April, the FDA ordered Bayer and other manufacturers of contraceptives to issue stronger warning labels. Pills that contain drospirenone, a synthetic hormone, must carry labels indicating that the risk of blood clots may triple when the drug is used.

The lawsuits have been consolidated in federal court as multidistrict litigation, and the combined case is currently the largest in the federal court system. The case is in pretrial proceedings in the Southern District of Illinois.

Vascular PRN is known for helping the medical field with foot and leg sequential compression devices, bariatric equipment, and the Skin IQ™ mattress coverlet that drastically helps to prevent these never events. Vascular PRN has decades of experience helping hospitals, nursing homes, surgery centers, and other institutions with their compression therapy rentals and sales. To learn more about a Sequential Compression Device, SCD boots, or the Skin IQ™ coverlet, visit www.vascularprn.com or call 800-886-4331.

Vascular PRN
601 S. Falkenburg Road, Suite 1-4
Tampa, FL 33619
Phone: 800.886.4331


View Larger Map

  • Intermittent Pneumatic Compression: The New Standard of Care for Preventing VTE in Stroke Patients?
    By GA Wardle Reviewed by Alan S. Weinstein, MD, FACP, Senior Physician Advisor, Virtua Fox Chase Cancer Program, Marlton, NJ Physical methods for prevention of deep vein thrombosis (DVT)—including intermittent pneumatic compression (IPC)—have documented efficacy in surgical patients. As recently as 2010, however, a Cochrane review found insufficient evidence to recommend IPC in stroke patients, […]
  • Antidepressant use increases hip fracture risk among elderly
    from: Medical New Today .com Antidepressant use nearly doubles the risk of hip fracture among community-dwelling persons with Alzheimer’s disease, according to a new study from the University of Eastern Finland. The increased risk was highest at the beginning of antidepressant use and remained elevated even 4 years later. The findings were published in the […]
  • Public Wants Well-Rested Medical Residents to Ensure Safe Patient Care
    A new national poll shows that the vast majority of the American public favors restricting the work shifts of medical residents (also known as resident physicians) to no more than 16 straight hours without sleep, according to a press release from Public Citizen. Importantly, 86% of the public is opposed to lifting the 16-hour cap […]

See other news sources publishing this article. BETA | Tags: , , , , , ,



Get headlines from Law Firm Newswire sent right to your inbox.

* indicates required